Form 8-K - Current report:
SEC Accession No. 0001079973-24-001666
Filing Date
2024-12-06
Accepted
2024-12-06 06:00:12
Documents
20
Period of Report
2024-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 43597
2 FORM OF SENIOR SECURED CONVERTIBLE NOTE ex4x1.htm EX-4.1 245429
3 FORM OF WARRANT ex4x2.htm EX-4.2 102697
4 FORM OF SECURITIES PURCHASE AGREEMENT ex10x1.htm EX-10.1 275278
5 FORM OF SECURITY AGREEMENT ex10x2.htm EX-10.2 148747
6 SUBSIDIARY GUARANTEE ex10x3.htm EX-10.3 82461
7 FORM OF SUPPORT AGREEMENT ex10x4.htm EX-10.4 21965
  Complete submission text file 0001079973-24-001666.txt   1365666

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE scpx-20241205.xsd EX-101.SCH 3549
9 XBRL DEFINITION FILE scpx-20241205_def.xml EX-101.DEF 26579
10 XBRL LABEL FILE scpx-20241205_lab.xml EX-101.LAB 36527
11 XBRL PRESENTATION FILE scpx-20241205_pre.xml EX-101.PRE 25203
22 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 241530414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)